STROMATT SCOTT 4
4 · CELL THERAPEUTICS INC · Filed Jun 22, 2006
Insider Transaction Report
Form 4
STROMATT SCOTT
EVP, Clinical Dev & Reg Affair
Transactions
- Sale
Common Stock
2006-06-20$1.40/sh−10,000$14,000→ 65,000 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Proceeds from the sale were used to cover taxes related to the vesting of restricted stock on June 16, 2006.